Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kirkman is a specialized nutraceutical company that focuses on providing high-purity dietary supplements for individuals with complex health needs, including those on the autism spectrum. Established in 1949, the company has built a reputation for its Ultra Tested protocol, which screens for over 950 environmental contaminants in its products. Their portfolio includes a comprehensive range of hypoallergenic vitamins, minerals, probiotics, and digestive enzymes designed to support neurological and gastrointestinal health. In late 2023, Kirkman was acquired by Sovereign Laboratories, a move intended to synergize their expertise in specialized nutrition and colostrum-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kirkman Labs.